EuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
EuroHospital Varna is the largest private hospital in the city of Varna, Bulgaria, specializing in the treatment of orthopedic, surgical, gastroenterological and urological conditions. Over the years, the hospital has built a strong reputation in Varna and throughout Northeast Bulgaria as a leading center for orthopedics and traumatology. With a team of more than 100 specialists, including leading and well-established doctors in Bulgaria, the hospital attracts patients from all over the country, as well as international patients through cooperation with leading assistance companies in Europe.
Intermedica Group is one of the leading distributors of high-technology medical devices and equipment in Bulgaria and the region, supporting hospitals, clinics and physicians in improving patient care, efficiency and cost optimization. Over the past 15 years, the group has become a preferred partner to leading medical manufacturers and more than 270 healthcare institutions.
Oaklins’ team in Bulgaria acted as the exclusive M&A advisor to the founders of EuroHospital Varna, supporting them throughout the negotiation, due diligence and sale process.
Talk to the deal team
Related deals
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn moreBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Learn more